-
Vera Bril, BSc, FRCPC, MD - Individualized Treatment for Generalized Myasthenia Gravis: Targeting the Cause and Prioritizing the Patient
- 2025/01/28
- 再生時間: 33 分
- ポッドキャスト
-
サマリー
あらすじ・解説
For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/SZN865. CME credit will be available until January 20, 2026.
Individualized Treatment for Generalized Myasthenia Gravis: Targeting the Cause and Prioritizing the Patient
In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Support
This activity is supported by an educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC (which are both Johnson & Johnson companies).
Disclosure information is available at the beginning of the video presentation.